Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/9/2021
Chance Pharma In-Licenses Drug-Device Combo AER-901 from Aerami Ther...
2/9/2021
Drug Farm Closes $56M Financing to Advance Lead Hepatitis B Drug into ...
2/9/2021
CDE Issues the Technical Guidelines for Clinical Trial of Human Immuno...
2/9/2021
SCMP: Phase One Trade Deal Largely A "Failure", As Purchases Fall Well...
2/8/2021
Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak
2/8/2021
Bayer Receives Approval for Nubeqa in China for the Treatment of Men ...
2/8/2021
Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...
2/8/2021
BMS Granted Priority Review for NDA of Luspatercept in China
2/8/2021
IQVIA Conducts Survey of Physician Behaviors at the Internet Clinic Pl...
2/5/2021
JBM Healthcare Debuts IPO on the Main Board of HKSE
2/5/2021
CMS Acquires Dermatology Specialty Firm Luqa
2/5/2021
NMPA Holds National Drug Registration and Post Marketing Regulation Co...
2/4/2021
Local Drugmakers Dominated China's 4th Round of National VBP Again, As...
2/4/2021
CDE Issues the Technical Guidelines for Clinical Trial of Omalizumab B...
2/4/2021
Wyeth Wins Trademark Infringement and Unfair Competition Lawsuit in C...
2/4/2021
Xuanzhu Pharma Takes Over Combio to Expand Biologics Pipeline
2/3/2021
Illumina and Sequoia Capital China Announce Deal to Incubate Genomics...
2/3/2021
Amgen/Celgene's NDA for Apremilast Accepted in China
2/3/2021
MNCs Secure Multiple New Drug Approvals in China
2/3/2021
AJMC: China Pulls Out Stops for Biosimilar Development
2/2/2021
More A Share-Listed Chinese MedPharm Cos Report 2020 Performance Guida...
2/2/2021
Harbour BioMed and ProBioGen Agree on a GlymaxX License to Fast-Track ...
2/2/2021
Astellas Granted Chinese Approval of XOSPATA (Gilteritinib)
2/2/2021
WuXi STA to Acquire BMS's Manufacturing Facility in Couvet, Switzerlan...
2/2/2021
Eli Lilly Reports 2020 Performance/2021 Outlook, Highlighting Volume G...
2/2/2021
Innovent and Lilly Announce Chinese Approval of TYVYT Combo for nsq...
2/2/2021
Bayer: Successfully Protected Legal Rights of "Kangwang" Trademark
2/1/2021
NHSA Issues Two Documents for Inter-provincial Direct Settlement of BM...
2/1/2021
Coherus and Junshi Enter Licensing Deal for Toripalimab in North Ameri...
2/1/2021
Antengene Partners with WuXi Biologics / WuXi STA to Advance Antibody-...
Page:
74
/
333
Total number of articles:
9989
:
[First]
[<<]
[72]
[73]
[74]
[75]
[76]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit